Bioblast Pharma Ltd.

Available to platforms

Bioblast Pharma Ltd. (Ticker: ORPN) was a biopharmaceutical company focused on developing treatments for rare and ultra-rare genetic diseases. The company's lead product candidate, Trehalose, was investigated for its potential to treat conditions such as oculopharyngeal muscular dystrophy (OPMD) and spinocerebellar ataxia. Following challenges in its clinical development, Bioblast ceased operations, and its stock was delisted.

Bioblast Pharma Ltd. - ORPN stocks live chart

Analyze price movements of Bioblast Pharma Ltd. online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous ORPN quotes – including the latest bid at 10.42 USD and ask at 12.23 USD – and get all the necessary information for adding Bioblast Pharma Ltd. to your investment portfolio.

With R StocksTrader, you can invest in Bioblast Pharma Ltd. and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like Bioblast Pharma Ltd., and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of ORPN does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Bioblast Pharma Ltd. (ORPN).

You can trade Bioblast Pharma Ltd. (ORPN) on the R StocksTrader platform.

You can trade online Bioblast Pharma Ltd. (ORPN) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts